CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | Piacquad David SVP, Business Development | Grant or award | +709 | 45,146 | ||
| 2021-04-30 | Piacquad David SVP, Business Development | Grant or award · Nqso (Right to Buy) | +6,159 | 6,159 | ||
| 2021-04-30 | Louie Linda H. VP, Finance & CAO | Grant or award | +300 | 8,301 | ||
| 2021-04-30 | Louie Linda H. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +2,608 | 2,608 | ||
| 2021-04-30 | Johnston Lori A EVP, HR | Grant or award | +3,296 | 38,055 | ||
| 2021-04-30 | Johnston Lori A EVP, HR | Grant or award · Nqso (Right to Buy) | +28,623 | 28,623 | ||
| 2021-04-30 | Grygiel Nancy A. SVP & CCO | Grant or award | +584 | 12,578 | ||
| 2021-04-30 | Grygiel Nancy A. SVP & CCO | Grant or award · Nqso (Right to Buy) | +5,072 | 5,072 | ||
| 2021-04-30 | Griffith Peter H. EVP & CFO | Grant or award | +3,338 | 25,960 | ||
| 2021-04-30 | Griffith Peter H. EVP & CFO | Grant or award · Nqso (Right to Buy) | +28,985 | 28,985 | ||
| 2021-04-30 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award | +3,797 | 47,762 | ||
| 2021-04-30 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award · Nqso (Right to Buy) | +32,971 | 32,971 | ||
| 2021-04-30 | Gordon Murdo EVP Global Commercial Ops | Grant or award | +4,172 | 45,630 | ||
| 2021-04-30 | Gordon Murdo EVP Global Commercial Ops | Grant or award · Nqso (Right to Buy) | +36,231 | 36,231 | ||
| 2021-04-30 | Bradway Robert A Chairman, CEO and President | Grant or award | +13,280 | 599,925 | ||
| 2021-04-30 | Bradway Robert A Chairman, CEO and President | Grant or award · Nqso (Right to Buy) | +115,307 | 115,307 | ||
| 2021-04-30 | Kullman Ellen Jamison Director | Grant or award | +135.62 | 7,093.62 | ||
| 2021-04-30 | HOLLEY CHARLES M Director | Grant or award | +166.92 | 4,256.44 | ||
| 2021-04-27 | Santos Esteban EVP, Operations | Shares withheld for taxes | −564 | $255.52 | $144K | 48,480 |
| 2021-04-27 | REESE DAVID M EVP, Research and Development | Shares withheld for taxes | −174 | $255.52 | $44K | 42,320 |
Page 32 of 35 · 698 trades